Guiding principles for the care of older adults with multimorbidity: An approach for clinicians: American Geriatrics Society expert panel on the care of older adults with multimorbidity

Journal of the American Geriatrics Society

Volumn 60, Issue 10, 2012, Pages

  Ickowicz, Elvy ^a  

^a American Geriatrics Society   (United States)

Author keywords

comorbidity; guiding principles; multimorbidity; older adults

Indexed keywords

CHRONIC DISEASE; CLINICAL PRACTICE; ELDERLY CARE; EVIDENCE BASED PRACTICE; HUMAN; MEDICAL SOCIETY; MORBIDITY; PATIENT CARE PLANNING; PATIENT PREFERENCE; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; RISK REDUCTION;

EID: 84867485730     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2012.04188.x     Document Type: Review

References (222)

1. Boyd CM, Fortin M,. Future of multimorbidity research: How should understanding of multimorbidity inform health system design? Public Health Rev 2011; 32: 451-474.
2. Mercer SW, Smith SM, Wyke S, et al. Multimorbidity in primary care: Developing the research agenda. Fam Pract 2009; 26: 79-80.
3. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: Implications for pay for performance. JAMA 2005; 294: 716-724.
4. Valderas JM, Starfield B, Sibbald B, et al. Defining comorbidity: Implications for understanding health and health services. Ann Fam Med 2009; 7: 357-363.
5. Anderson G,. Chronic Care: Making the Case for Ongoing Care. Princeton, NJ: Robert Wood Johnson Foundation, 2010.
6. Boult C, Wieland GD,. Comprehensive primary care for older patients with multiple chronic conditions: "Nobody rushes you through." JAMA 2010; 304: 1936-1943.
7. Counsell SR, Callahan CM, Clark DO, et al. Geriatric care management for low-income seniors: A randomized controlled trial. JAMA 2007; 298: 2623-2633.
8. Eng C, Pedulla J, Eleazer GP, et al. Program of All-Inclusive Care for the Elderly (PACE): An innovative model of integrated geriatric care and financing. J Am Geriatr Soc 1997; 45: 223-232.
9. Tinetti ME, Bogardus ST, Agostini JV,. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 2004; 351: 2870-2874.
10. Mutasingwa DR, Ge H, Upshur RE,. How applicable are clinical practice guidelines to elderly patients with comorbidities? Can Fam Physician 2011; 57: e253-e262.
11. Cox L, Kloseck M, Crilly R, et al. Underrepresentation of individuals 80 years of age and older in chronic disease clinical practice guidelines. Can Fam Physician 2011; 57: e263-e269.
12. Lugtenberg M, Burgers JS, Clancy C, et al. Current guidelines have limited applicability to patients with comorbid conditions: A systematic analysis of evidence-based guidelines. PLoS One 2011; 6: e25987.
13. Fortin M, Contant E, Savard C, et al. Canadian guidelines for clinical practice: An analysis of their quality and relevance to the care of adults with comorbidity. BMC Fam Pract 2011; 12: 74.
14. Covinsky KE, Eng C, Lui LY, et al. The last 2 years of life: Functional trajectories of frail older people. J Am Geriatr Soc 2003; 51: 492-498.
15. Lunney JR, Lynn J, Hogan C,. Profiles of older Medicare decedents. J Am Geriatr Soc 2002; 50: 1108-1112.
16. Grant RW, Ashburner JM, Hong CC, et al. Defining patient complexity from the primary care physician's perspective: A cohort study. Ann Intern Med 2011; 155: 797-804.
17. Boyd CM, Boult C, Shadmi E, et al. Guided care for multi-morbid older adults. The Gerontologist 2007; 47: 697-704.
18. Flaherty JH, Morley JE, Murphy DJ, et al. The development of outpatient clinical glidepaths. J Am Geriatr Soc 2002; 50: 1886-1901.
19. Krahn M,. 'New' evidence for clinical practice guidelines: Should we search for 'preference evidence'? Patient 2010; 3: 71-77.
20. Chong CA, Chen IJ, Naglie G, et al. How well do guidelines incorporate evidence on patient preferences? J Gen Intern Med 2009; 24: 977-982.
21. Fried TR, Tinetti ME, Iannone L,. Primary care clinicians' experiences with treatment decision making for older persons with multiple conditions. Arch Intern Med 2011; 171: 75-80.
22. Fried TR, Tinetti M, Agostini J, et al. Health outcome prioritization to elicit preferences of older persons with multiple health conditions. Patient Educ Couns 2011; 83: 278-282.
23. van der Weijden T, Légaré F, Boivin A, et al. How to integrate individual patient values and preferences in clinical practice guidelines? A research protocol Implement Sci 2010; 5: 10.
24. Joosten EA, defuentes-Merillas L, de Weert GH, et al. Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother Psychosom 2008; 77: 219-226.
25. Durso S,. The next frontier: Quantifying risks for interventions with no end in sight. Arch Intern Med 2008; 168: 1230-1231.
26. Reuben DB, Tinetti ME,. Goal-oriented patient care-an alternative health outcomes paradigm. N Engl J Med 2012; 366: 777-779.
27. Loke YK, Cavallazzi R, Singh S,. Risk of fractures with inhaled corticosteroids in COPD: Systematic review and meta-analysis of randomised controlled trials and observational studies. Thorax 2011; 66: 699-708.
28. Abd TT, Jacobson TA,. Statin-induced myopathy: A review and update. Expert Opin Drug Saf 2011; 10: 373-387.
29. Evans MA, Golomb BA,. Statin-associated adverse cognitive effects: Survey results from 171 patients. Pharmacotherapy 2009; 29: 800-811.
30. Agostini JV, Han L, Tinetti ME,. The relationship between number of medications and weight loss or impaired balance in older adults. J Am Geriatr Soc 2004; 52: 1719-1723.
31. Fried TR, McGraw S, Agostini JV, et al. Views of older persons with multiple morbidities on competing outcomes and clinical decision-making. J Am Geriatr Soc 2008; 56: 1839-1844.
32. Belcher VN, Fried TR, Agostini JV, et al. Views of older adults on patient participation in medication-related decision making. J Gen Intern Med 2006; 21: 298-303.
33. Nakao MA, Axelrod S,. Numbers are better than words. Verbal specifications of frequency have no place in medicine. Am J Med 1983; 74: 1061-1065.
34. Mcneil BJ, Pauker SG, Sox HC Jr, et al. On the elicitation of preferences for alternative therapies. N Engl J Med 1982; 306: 1259-1262.
35. Apter AJ, Paasche-Orlow MK, Remillard JT, et al. Numeracy and communication with patients: They are counting on us. J Gen Intern Med 2008; 23: 2117-2124.
36. Golbeck AL, Ahlers-Schmidt CR, Paschal AM, et al. A definition and operational framework for health numeracy. Am J Prev Med 2005; 29: 375-376.
37. Reyna VF, Nelson WL, Han PK, et al. How numeracy influences risk comprehension and medical decision making. Psychol Bull 2009; 135: 943-973.
38. O'Connor AM, Bennett CL, Stacey D, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2009; 3: CD001431.
39. Fraenkel L, Fried TR,. Individualized medical decision making: Necessary, achievable, but not yet attainable. Arch Intern Med 2010; 170: 566-569.
40. Assessing Desirability of Outcome States for Medical Decision Making and Cost-Effectiveness Analysis [on-line]. Available at http://painconsortium.nih. gov/symptomresearch/chapter-24/index.htma Accessed July 30, 2012.
41. Elwyn G, Edwards A, Eccles M, et al. Decision analysis in patient care. Lancet 2001; 358: 571-574.
42. Pauker SG, Kassirer JP,. Decision analysis. N Engl J Med 1987; 316: 250-258.
43. Farrar S, Ryan M, Ross D, et al. Using discrete choice modelling in priority setting: An application to clinical service developments. Soc Sci Med 2000; 50: 63-75.
44. Sachs GA,. Dementia and the goals of care. J Am Geriatr Soc 1998; 46: 782-783.
45. Deber RB,. Physicians in health care management: 8. The patient-physician partnership: Decision making, problem solving and the desire to participate. Can Med Assoc J 1994; 151: 423-427.
46. Levinson W, Kao A, Kuby A, et al. Not all patients want to participate in decision making. A national study of public preferences. J Gen Intern Med 2005; 20: 531-535.
47. Kapp MB,. Health care decision making by the elderly: I get by with a little help from my family. Gerontologist 1991; 31: 619-623.
48. Fried TR, Byers AL, Gallo WT, et al. Prospective study of health status preferences and changes in preferences over time in older adults. Arch Intern Med 2006; 166: 890-895.
49. Luce JM,. Physicians do not have a responsibility to provide futile or unreasonable care if a patient or family insists. Crit Care Med 1995; 23: 760-766.
50. Alaszewski A, Horlick-Jones T,. How can doctors communicate information about risk more effectively? BMJ 2003; 327: 728-731.
51. Politi MC, Han PK, Col NF,. Communicating the uncertainty of harms and benefits of medical interventions. Med Decis Making 2007; 27: 681-695.
52. Ostbye T, Yarnall KS, Krause KM, et al. Is there time for management of patients with chronic diseases in primary care? Ann Fam Med 2005; 3: 209-214.
53. Levenson SA, Morley JE,. Evidence rocks in long-term care, but does it roll? J Am Med Dir Assoc 2007; 8: 493-501.
54. Welch HG, Albertsen PC, Nease RF, et al. Estimating treatment benefits for the elderly: The effect of competing risks. Ann Intern Med 1996; 124: 577-584.
55. Guyatt G, Rennie DE, eds. Users' Guides to the Medical Literature: A Manual of Evidence-Based Clinical Practice. Chicago, IL: AMA Press, 2002.
56. Sackett D, Tugwell P, Guyatt G, eds. Clinical Epidemiology: A Basic Science for Clinical Medicine, 2nd ed. Boston: Little, Brown, 1991.
57. Institute of Medicine. Clinical Practice Guidelines We Can Trust [on-line]. Available at http://www.iom.edu/~/media/Files/Report%20Files/2011/ Clinical-Practice-Guidelines-We-Can-Trust/ Clinical%20Practice%20Guidelines%202011%20Insert.pdf Accessed July 30, 2012.
58. Institute of Medicine. Finding What Works in Health Care: Standards for Systematic Reviews [on-line]. Available at http://www.iom.edu/~/media/Files/ Report%20Files/2011/Finding-What-Works-in-Health-Care-Standards-for-Systematic- Reviews/Standards%20for%20Systematic%20Review%202010%20Insert.pdf Accessed July 30, 2012.
59. GRADE Working Group [on-line]. Available at http://www.gradeworkinggroup. org/index.htm Accessed July 30, 2012.
60. McClellan MB, mcginnis JM, Nabel EG, et al. Evidence-Based Medicine and the Changing Nature of Health Care: 2007. IOM Annual Meeting Summary, 2008.
61. Oxford Centre for Evidence-Based Medicine [on-line]. Available at http://www.cebm.net/index.aspx?O=1025 Accessed July 30, 2012.
62. The Cochrane Collaboration [on-line]. Available at http://www.cochrane. org/ Accessed July 30, 2012.
63. AHRQ Effective Health Care Program Stakeholder Guide. AHRQ Publication No. 11-EHC069-EF. Rockville, MD: Agency for Healthcare Research and Quality, 2011.
64. Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011; 64: 383-394.
65. Fuchs VR, Garber AM,. The new technology assessment. N Engl J Med 1990; 323: 673-677.
66. Montori VM, Shah ND,. What have we learnt from the rosiglitazone saga? BMJ 2011; 342: d1354.
67. Fried TR, Tinetti ME, Towle V, et al. Effects of benefits and harms on older persons' willingness to take medication for primary cardiovascular prevention. Arch Intern Med 2011; 171: 923-928.
68. Walter LC, Covinsky KE,. Cancer screening in elderly patients: A framework for individualized decision making. JAMA 2001; 285: 2750-2756.
69. Kent DM, Hayward RA,. Limitations of applying summary results of clinical trials to individual patients: The need for risk stratification. JAMA 2007; 298: 1209-1212.
70. Kent DM, Kitsios G,. Against pragmatism: On efficacy, effectiveness and the real world. Trials 2009; 10: 48.
71. Varadhan R, Weiss CO, Segal JB, et al. Evaluating health outcomes in the presence of competing risks: A review of statistical methods and clinical applications. Med Care 2010; 48 (6 Suppl): S96-S105.
72. Koller MT, Raatz H, Steyerberg EW, et al. Competing risks and the clinical community: Irrelevance or ignorance? Stat Med 2011; 31: 1089-1097.
73. Blaum CS, Cigolle CT, Boyd C, et al. Clinical complexity in middle-aged and older adults with diabetes: The Health and Retirement Study. Med Care 2010; 48: 327-334.
74. Ioannidis JP,. Why most published research findings are false: Author's reply to Goodman and Greenland. PloS Med 2007; 4: e215.
75. Allen D, Harkins KJ,. Too much guidance? Lancet 2005; 365: 1768.
76. Grol R,. Has guideline development gone astray? Yes. BMJ 2010; 340: c306.
77. Reuben DB,. Medical care for the final years of life: "When you're 83, it's not going to be 20 years." JAMA 2009; 302: 2686-2694.
78. Covinsky KE, Hilton J, Lindquist K, et al. Development and validation of an index to predict activity of daily living dependence in community-dwelling elders. Med Care 2006; 44: 149-157.
79. Studenski S, Perera S, Patel K, et al. Gait speed and survival in older adults. JAMA 2011; 305: 50-58.
80. U.S. Preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009; 150: 396-404.
81. Brown AF, Mangione CM, Saliba D, et al. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 2003; 51: S265-80.
82. Glare PA, Sinclair CT,. Palliative medicine review: Prognostication. J Palliat Med 2008; 11: 84-103.
83. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010; 363: 733-742.
84. Connor SR, Pyenson B, Fitch K, et al. Comparing hospice and nonhospice patient survival among patients who die within a three-year window. J Pain Symptom Manage 2007; 33: 238-246.
85. Ahalt C, Walter LC, Yourman L, et al. "Knowing is better": Preferences of diverse older adults for discussing prognosis. J Gen Intern Med 2011; 27: 568-575.
86. Smith AK, Williams BA, Lo B,. Discussing overall prognosis with the very elderly. N Engl J Med 2011; 365: 2149-2151.
87. Adler R, Kamel H,. Doorway Thoughts: Cross-Cultural Health Care for Older Adults. Sudbury, MA: Jones and Bartlett Publishers, 2004.
88. Yourman LC, Lee SJ, Schonberg MA,. Prognostic indices for older adults: A systematic review. JAMA 2012; 307: 182-192.
89. Minne L, Ludikhuize J, de Rooij SE, et al. Characterizing predictive models of mortality for older adults and their validation for use in clinical practice. J Am Geriatr Soc 2011; 59: 1110-1115.
90. Levy WC, Mozaffarian D, Linker DT, et al. The Seattle Heart Failure Model: Prediction of survival in heart failure. Circulation 2006; 113: 1424-1433.
91. Ong KC, Earnest A, Lu SJ,. A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest 2005; 128: 3810-3816.
92. Mitchell SL, Miller SC, Teno JM, et al. Prediction of 6-month survival of nursing home residents with advanced dementia using ADEPT vs hospice eligibility guidelines. JAMA 2010; 304: 1929-1935.
93. Marengoni A, Von Strauss E, Rizzuto D, et al. The impact of chronic multimorbidity and disability on functional decline and survival in elderly persons. A community-based, longitudinal study. J Intern Med 2009; 265: 288-295.
94. Lee SJ, Lindquist K, Segal MR, et al. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 2006; 295: 801-808.
95. Schonberg MA, Davis RB, McCarthy EP, et al. External validation of an index to predict up to 9-year mortality of community-dwelling adults aged 65 and older. J Am Geriatr Soc 2011; 59: 1444-1451.
96. Min L, Yoon W, Mariano J, et al. The Vulnerable Elders-13 Survey predicts 5-year functional decline and mortality outcomes in older ambulatory care patients. J Am Geriatr Soc 2009; 57: 2070-2076.
97. Schonberg MA, Davis RB, McCarthy EP, et al. Index to predict 5-year mortality of community-dwelling adults aged 65 and older using data from the National Health Interview Survey. J Gen Intern Med 2009; 24: 1115-1122.
98. Maltoni M, Nanni O, Pirovano M, et al. Successful validation of the palliative prognostic score in terminally ill cancer patients. Italian Multicenter Study Group on Palliative Care. J Pain Symptom Manage 1999; 17: 240-247.
99. Harrold J, Rickerson E, Carroll JT, et al. Is the Palliative Performance Scale a useful predictor of mortality in a heterogeneous hospice population? J Palliat Med 2005; 8: 503-509.
100. Morita T, Tsunoda J, Inoue S, et al. Validity of the Palliative Performance Scale from a survival perspective. J Pain Symptom Manage 1999; 18: 2-3.
101. Mehta KM, Pierluissi E, Boscardin WJ, et al. A clinical index to stratify hospitalized older adults according to risk for new-onset disability. J Am Geriatr Soc 2011; 59: 1206-1216.
102. Stuart B, The NHO,. Medical guidelines for non-cancer disease and local medical review policy: Hospice access for patients with diseases other than cancer. Hosp J 1999; 14: 139-154.
103. Siontis GC, Tzoulaki I, Ioannidis JP,. Predicting death: An empirical evaluation of predictive tools for mortality. Arch Intern Med 2011; 171: 1721-1726.
104. Fox E, Landrum-McNiff K, Zhong Z, et al. Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease. SUPPORT investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. JAMA 1999; 282: 1638-1645.
105. Christakis NA, Escarce JJ,. Survival of Medicare patients after enrollment in hospice programs. N Engl J Med 1996; 335: 172-178.
106. Kripalani S, Yao X, Haynes RB,. Interventions to enhance medication adherence in chronic medical conditions: A systematic review. Arch Intern Med 2007; 167: 540-550.
107. Kavanagh BP,. The GRADE system for rating clinical guidelines. PLoS Med 2009; 6: e1000094.
108. Nolan TW,. System changes to improve patient safety. BMJ 2000; 320: 771-773.
109. George J, Phun YT, Bailey MJ, et al. Development validation of the medication regimen complexity index. Ann Pharmacother 2004; 38: 1369-1376.
110. George J, Vuong T, Bailey MJ, et al. Medication regimen complexity and adherence in patients at risk of medication misadventure. J Pharm Pract Res 2006; 36: 99-102.
111. Cherubini A, Ruggiero C, Gasperini B, et al. The prevention of adverse drug reactions in older subjects. Curr Drug Metab 2011; 12: 652-657.
112. Gijsen R, Hoeymans N, Schellevis FG, et al. Causes and consequences of comorbidity: A review. J Clin Epidemiol 2001; 54: 661-674.
113. Giovannetti ER, Wolff JL, Xue QL, et al. Difficulty assisting with health care tasks among caregivers of multimorbid older adults. J Gen Intern Med 2012; 27: 37-44.
114. Morris RL, Sanders C, Kennedy AP, et al. Shifting priorities in multimorbidity: A longitudinal qualitative study of patient's prioritization of multiple conditions. Chronic Illn 2011; 7: 147-161.
115. Elliott RA, Ross-Degnan D, Adams AS, et al. Strategies for coping in a complex world: Adherence behavior among older adults with chronic illness. J Gen Intern Med 2007; 22: 805-810.
116. Kennedy JJ, Maciejewski M, Liu D, et al. Cost-related nonadherence in the Medicare program: The impact of part D. Med Care 2011; 49: 522-526.
117. Brown MT, Bussell JK,. Medication adherence: WHO cares? Mayo Clin Proc 2011; 86: 304-314.
118. Farris KB, Phillips BB,. Instruments assessing capacity to manage medications. Ann Pharmacother 2008; 42: 1026-1036.
119. Haslbeck JW, Schaeffer D,. Routines in medication management: The perspective of people with chronic conditions. Chronic Illn 2009; 5: 184-196.
120. Nobili A, Licata G, Salerno F, et al. Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study. Eur J Clin Pharmacol 2011; 67: 507-519.
121. Kuzuya M, Hirakawa Y, Suzuki Y, et al. Association between unmet needs for medication support and all-cause hospitalization in community-dwelling disabled elderly people. J Am Geriatr Soc 2008; 56: 881-886.
122. Weiss M, Britten N,. What is concordance? Pharm J 2003; 271: 493.
123. Moen J, Norrgård S, Antonov K, et al. GPs' perceptions of multiple-medicine use in older patients. J Eval Clin Pract 2010; 16: 69-75.
124. Scott I, Jayathissa S,. Quality of drug prescribing in older patients: Is there a problem and can we improve it? Intern Med J 2010; 40: 7-18.
125. Bell CM, Brener SS, Gunraj N, et al. Association of ICU or hospital admission with unintentional discontinuation of medications for chronic diseases. JAMA 2011; 306: 840-847.
126. Bodenheimer T, Lorig K, Holman H, et al. Patient self-management of chronic disease in primary care. JAMA 2002; 288: 2469-2475.
127. Wehling M,. Multimorbidity and polypharmacy: How to reduce the harmful drug load and yet add needed drugs in the elderly? proposal of a new drug classification: Fit for the aged. J Am Geriatr Soc 2009; 57: 560-561.
128. Steinman MA, Landefeld CS, Rosenthal GE, et al. Does the number of coexisting chronic diseases affect the adverse association between polypharmacy and prescribing quality in older adults? response. J Am Geriatr Soc 2007; 55: 803-804.
129. Lampert R, Hayes DL, Annas GJ, et al. HRS expert consensus statement on the management of cardiovascular implantable electronic devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm 2010; 7: 1008-1026.
130. Crentsil V, Ricks MO, Xue QL, et al. A pharmacoepidemiologic study of community-dwelling, disabled older women: Factors associated with medication use. Am J Geriatr Pharmacother 2010; 8: 215-224.
131. Chrischilles E, Rubenstein L, Van Gilder R, et al. Risk factors for adverse drug events in older adults with mobility limitations in the community setting. J Am Geriatr Soc 2007; 55: 29-34.
132. Gagne JJ, Maio V, Rabinowitz C,. Prevalence and predictors of potential drug-drug interactions in regione Emilia-Romagna, Italy. J Clin Pharm Ther 2008; 33: 141-151.
133. Nobili A, Pasina L, Tettamanti M, et al. Potentially severe drug interactions in elderly outpatients: Results of an observational study of an administrative prescription database. J Clin Pharm Ther 2009; 34: 377-386.
134. Corsonello A, Pedone C,. Antonelli Incalzi R. Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. Curr Med Chem 2010; 17: 571-584.
135. Hanlon JT, Wang X, Handler SM, et al. Potentially inappropriate prescribing of primarily renally cleared medications for older Veterans Affairs nursing home patients. J Am Med Dir Assoc 2011; 12: 377-383.
136. The American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012; 2012 (60): 616-631.
137. Gallagher P, O'Mahony D,. STOPP (Screening Tool of Older Persons' Potentially Inappropriate Prescriptions): Application to acutely ill elderly patients and comparison with beers' criteria. Age Ageing 2008; 37: 673-679.
138. Chang CB, Chan DC,. Comparison of published explicit criteria for potentially inappropriate medications in older adults. Drugs Aging 2010; 27: 947-957.
139. Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: How well can it be measured and optimised? Lancet 2007; 370: 173-184.
140. Samsa GP, Hanlon JT, Schmader KE, et al. A summated score for the medication appropriateness index: Development and assessment of clinimetric properties including content validity. J Clin Epidemiol 1994; 47: 891-896.
141. Garfinkel D, Mangin D,. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: Addressing polypharmacy. Arch Intern Med 2010; 170: 1648-1654.
142. Hilmer SN, Mager DE, Simonsick EM, et al. Drug Burden Index Score and functional decline in older people. Am J Med 2009; 122: 1142-1149.e2.
143. Rudolph JL, Salow MJ, Angelini MC, et al. The Anticholinergic Risk Scale and anticholinergic adverse effects in older persons. Arch Intern Med 2008; 168: 508-513.
144. Cahir C, Fahey T, Teeling M, et al. Potentially inappropriate prescribing and cost outcomes for older people: A national population study. Br J Clin Pharmacol 2010; 69: 543-552.
145. Hanlon JT, Schmader KE,. What types of inappropriate prescribing predict adverse drug reactions in older adults? Ann Pharmacother 2010; 44: 1110-1111.
146. Morandi A, Vasilevskis EE, Pandharipande PP, et al. Inappropriate medications in elderly ICU survivors: Where to intervene? Arch Intern Med 2011; 171: 1032-1034.
147. Cashman J, Wright J, Ring A,. The treatment of co-morbidities in older patients with metastatic cancer. Support Care Cancer 2010; 18: 651-655.
148. Holmes HM, Sachs GA, Shega JW, et al. Integrating palliative medicine into the care of persons with advanced dementia: Identifying appropriate medication use. J Am Geriatr Soc 2008; 56: 1306-1311.
149. Spiess JL, Can I,. stop the warfarin? A review of the risks and benefits of discontinuing anticoagulation. J Palliat Med 2009; 12: 83-87.
150. Riechelmann RP, Krzyzanowska MK, Zimmermann C,. Futile medication use in terminally ill cancer patients. Support Care Cancer 2009; 17: 745-748.
151. Stevenson J, Abernethy AP, Miller C, et al. Managing comorbidities in patients at the end of life. BMJ 2004; 329: 909-912.
152. Currow DC, Stevenson JP, Abernethy AP, et al. Prescribing in palliative care as death approaches. J Am Geriatr Soc 2007; 55: 590-595.
153. Holmes HM, Hayley DC, Alexander GC, et al. Reconsidering medication appropriateness for patients late in life. Arch Intern Med 2006; 166: 605-609.
154. Fitzgerald SP, Bean NG,. An analysis of the interactions between individual comorbidities and their treatments-implications for guidelines and polypharmacy. J Am Med Dir Assoc 2010; 11: 475-484.
155. Moen J, Bohm A, Tillenius T, et al. "I don't know how many of these [medicines] are necessary."-A focus group study among elderly users of multiple medicines. Patient Educ Couns 2009; 74: 135-141.
156. Rochon PA, Gurwitz JH,. Optimising drug treatment for elderly people: The prescribing cascade. BMJ 1997; 315: 1096-1099.
157. Schiff GD, Galanter WL, Duhig J, et al. Principles of conservative prescribing. Arch Intern Med 2011; 171: 1433-1440.
158. Soumerai SB, Pierre-Jacques M, Zhang F, et al. Cost-related medication nonadherence among elderly and disabled Medicare beneficiaries: A national survey 1 year before the Medicare drug benefit. Arch Intern Med 2006; 166: 1829-1835.
159. Briesacher BA, Gurwitz JH, Soumerai SB,. Patients at-risk for cost-related medication nonadherence: A review of the literature. J Gen Intern Med 2007; 22: 864-871.
160. Modig S, Kristensson J, Ekwall AK, et al. Frail elderly patients in primary care-their medication knowledge and beliefs about prescribed medicines. Eur J Clin Pharmacol 2009; 65: 151-155.
161. Graves T, Hanlon JT, Schmader KE, et al. Adverse events after discontinuing medications in elderly outpatients. Arch Intern Med 1997; 157: 2205-2210.
162. Bain KT, Holmes HM, Beers MH, et al. Discontinuing medications: A novel approach for revising the prescribing stage of the medication-use process. J Am Geriatr Soc 2008; 56: 1946-1952.
163. Castelino RL, Bajorek BV, Chen TF,. Targeting suboptimal prescribing in the elderly: A review of the impact of pharmacy services. Ann Pharmacother 2009; 43: 1096-1106.
164. Doucette WR, McDonough RP, Klepser D, et al. Comprehensive medication therapy management: Identifying and resolving drug-related issues in a community pharmacy. Clin Ther 2005; 27: 1104-1111.
165. Abernethy AP, Aziz NM, Basch E, et al. A strategy to advance the evidence base in palliative medicine: Formation of a palliative care research cooperative group. J Palliat Med 2010; 13: 1407-1413.
166. Blozik E, Born AM, Stuck AE, et al. Reduction of inappropriate medications among older nursing-home residents: A nurse-led, prepost-design, intervention study. Drugs Aging 2010; 27: 1009-1017.
167. Suhrie EM, Hanlon JT, Jaffe EJ, et al. Impact of a geriatric nursing home palliative care service on unnecessary medication prescribing. Am J Geriatr Pharmacother 2009; 7: 20-25.
168. Mohs RC, Doody RS, Morris JC, et al. A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients. Neurology 2001; 57: 481-488.
169. Becker M, Andel R, Rohrer L, et al. The effect of cholinesterase inhibitors on risk of nursing home placement among Medicaid beneficiaries with dementia. Alzheimer Dis Assoc Disord 2006; 20: 147-152.
170. Geldmacher DS, Provenzano G, McRae T, et al. Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease. J Am Geriatr Soc 2003; 51: 937-944.
171. Kaduszkiewicz H, Zimmermann T, Beck-Bornholdt HP, et al. Cholinesterase inhibitors for patients with Alzheimer's disease: Systematic review of randomised clinical trials. BMJ 2005; 331: 321-327.
172. Courtney C, Farrell D, Gray R, et al. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): Randomised double-blind trial. Lancet 2004; 363: 2105-2115.
173. Birks J,. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev 2006;(1): CD005593.
174. Schneider LS, Dagerman KS, Higgins JP, et al. Lack of evidence for the efficacy of memantine in mild Alzheimer disease. Arch Neurol 2011; 68: 991-998.
175. Black DM, Schwartz AV, Ensrud KE, et al. Effects of continuing or stopping alendronate after 5 years of treatment: The Fracture Intervention Trial Long-Term Extension (FLEX): A randomized trial. JAMA 2006; 296: 2927-2938.
176. Brown AF, Mangione CM, Saliba D, et al. California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 2003; 51 (5 Suppl Guidelines): S265-S280.
177. Rait G, Walters K, Bottomley C, et al. Survival of people with clinical diagnosis of dementia in primary care: Cohort study. BMJ 2010; 341: c3584.
178. WHO Fracture Risk Assessment Tool [on-line]. Available at http://www.shef.ac.uk/FRAX/ Accessed July 30, 2012.
179. National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis [on-line]. Available at http://www.nof.org/sites/ default/files/pdfs/NOF-ClinicianGuide2009-v7.pdf Accessed July 30, 2012.
180. Nelson HD, Haney EM, Dana T, et al. Screening for osteoporosis: An update for the U.S. Preventive Services Task Force. Ann Intern Med 2010; 153: 99-111.
181. Mazzaglia G, Roti L, Corsini G, et al. Screening of older community-dwelling people at risk for death and hospitalization: The Assistenza Socio-Sanitaria in Italia Project. J Am Geriatr Soc 2007; 55: 1955-1960.
182. Micromedex [on-line]. Available at http://www.micromedex.com/ Accessed July 30, 2012.
183. O'Connell MB, Madden DM, Murray AM, et al. Effects of proton pump inhibitors on calcium carbonate absorption in women: A randomized crossover trial. Am J Med 2005; 118: 778-781.
184. Bab I, Yirmiya R,. Depression, selective serotonin reuptake inhibitors, and osteoporosis. Curr Osteoporos Rep 2010; 8: 185-191.
185. Ziere G, Dieleman JP, van der Cammen TJ, et al. Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures. J Clin Psychopharmacol 2008; 28: 411-417.
186. Wolff JL, Rand-Giovannetti E, Palmer S, et al. Caregiving and chronic care: The Guided Care Program for Families and Friends. J Gerontol A Biol Sci Med Sci 2009; 64A: 785-791.
187. Pham HH, Schrag D, O'Malley AS, et al. Care patterns in Medicare and their implications for pay for performance. N Engl J Med 2007; 356: 1130-1139.
188. Wennberg JE, Fisher ES, Skinner JS,. Geography and the debate over Medicare reform. Health Aff (Millwood) 2002;Suppl Web Exclusives: W96-W114.
189. Ford DE,. Optimizing outcomes for patients with depression and chronic medical illnesses. Am J Med 2008; 121 (11 Suppl 2): S38-S44.
190. Miles RW,. Fallacious reasoning and complexity as root causes of clinical inertia. J Am Med Dir Assoc 2007; 8: 349-354.
191. Turner J, Pugh J, Budiani D,. "It's always continuing": First-year medical students' perspectives on chronic illness and the care of chronically ill patients. Acad Med 2005; 80: 183-188.
192. Giovannetti ER, Xue Q, Reider L, et al. Factors Associated with Change in Health Care Task Difficulty Among Multimorbid Older Adults. National Harbor, MD: Presented at the Annual Meeting of the American Geriatrics Society, 2011.
193. Wolff JL, Boyd CM, Gitlin LN, et al. Going it together: Persistence of older adults' accompaniment to physician visits by a family companion. J Am Geriatr Soc 2012; 60: 106-112.
194. Mitnick S, Leffler C, Hood VL,. American College of Physicians Ethics, Professionalism and Human Rights Committee. Family caregivers, patients and physicians: Ethical guidance to optimize relationships. J Gen Intern Med 2010; 25: 255-260.
195. Sorensen S, Pinquart M, Duberstein P,. How effective are interventions with caregivers? An updated meta-analysis. Gerontologist 2002; 42: 356-372.
196. Schulz R, Beach SR,. Caregiving as a risk factor for mortality: The Caregiver Health Effects Study. JAMA 1999; 282: 2215-2219.
197. Whitson HE, Steinhauser K, Ammarell N, et al. Categorizing the effect of comorbidity: A qualitative study of individuals' experiences in a low-vision rehabilitation program. J Am Geriatr Soc 2011; 59: 1802-1809.
198. Larkey LK, Hecht ML, Miller K, et al. Hispanic cultural norms for health-seeking behaviors in the face of symptoms. Health Educ Behav 2001; 28: 65-80.
199. Mir G, Sheikh A,. 'Fasting and prayer don't concern the doctors... they don't even know what it is': Communication, decision-making and perceived social relations of Pakistani Muslim patients with long-term illnesses. Ethn Health 2010; 15: 327-342.
200. Schuz B, Marx C, Wurm S, et al. Medication beliefs predict medication adherence in older adults with multiple illnesses. J Psychosom Res 2011; 70: 179-187.
201. Thorne SE, Ternulf Nyhlin K, Paterson BL,. Attitudes toward patient expertise in chronic illness. Int J Nurs Stud 2000; 37: 303-311.
202. Coye MJ,. No Toyotas in health care: Why medical care has not evolved to meet patients' needs. Health Aff (Millwood) 2001; 20: 44-56.
203. Vogeli C, Shields AE, Lee TA, et al. Multiple chronic conditions: Prevalence, health consequences, and implications for quality, care management, and costs. J Gen Intern Med 2007; 22 (Suppl. 3): 391-395.
204. Snyder L, Neubauer RL,. Pay-for-performance principles that promote patient-centered care: An ethics manifesto. Ann Intern Med 2007; 147: 792-794.
205. Multiple Chronic Conditions-A Strategic Framework: Optimum Health and Quality of Life for Individuals with Multiple Chronic Conditions. Washington, DC: U.S. Department of Health and Human Services, 2010.
206. Measurement in a Complex World. National Quality Forum, Washington, DC [on-line]. Available at http://www.qualityforum.org/Projects/Multiple-Chronic- Conditions-Measurement-Framework.aspx Accessed July 30, 2012.
207. Thiem U, Theile G, Junius-Walker U, et al. Prerequisites for a new health care model for elderly people with multimorbidity: The PRISCUS Research Consortium. Z Gerontol Geriatr 2011; 44: 115-120.
208. Fick DM, Mion LC, Beers MH, et al. Health outcomes associated with potentially inappropriate medication use in older adults. Res Nurs Health 2008; 31: 42-51.
209. Dedhiya SD, Hancock E, Craig BA, et al. Incident use and outcomes associated with potentially inappropriate medication use in older adults. Am J Geriatr Pharmacother 2010; 8: 562-570.
210. Akazawa M, Imai H, Igarashi A, et al. Potentially inappropriate medication use in elderly Japanese patients. Am J Geriatc Pharmacother 2010; 8: 146-160.
211. Gnjidic D, Le Couteur DG, Abernethy DR, et al. Drug Burden Index and Beers Criteria: Impact on functional outcomes in older people living in self-care retirement villages. J Clin Pharmacol 2011 Feb 2. [Epub ahead of print]
212. Sakuma M, Morimoto T, Matsui K, et al. Epidemiology of potentially inappropriate medication use in elderly patients in Japanese acute care hospitals. Pharmacoepidemiol Drug Saf 2011; 20: 386-392.
213. Barnett K, McCowan C, Evans JM, et al. Prevalence and outcomes of use of potentially inappropriate medicines in older people: Cohort study stratified by residence in nursing home or in the community. BMJ Qual Saf 2011; 20: 275-281.
214. Harugeri A, Joseph J, Parthasarathi G, et al. Potentially inappropriate medication use in elderly patients: A study of prevalence and predictors in two teaching hospitals. J Postgrad Med 2010; 56: 186-191.
215. Corsonello A, Pedone C, Lattanzio F, et al. Potentially inappropriate medications and functional decline in elderly hospitalized patients. J Am Geriatr Soc 2009; 57: 1007-1014.
216. Budnitz DS, Lovegrove MC, Shehab N, et al. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011; 365: 2002-2012.
217. Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert Doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008; 46: 72-83.
218. Gallagher PF, O'Connor MN, O'Mahony D,. Prevention of potentially inappropriate prescribing for elderly patients: A randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther 2011; 89: 845-854.
219. Hellstrom LM, Bondesson A, Hoglund P, et al. Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits. Eur J Clin Pharmacol 2011; 67: 741-752.
220. Lund BC, Carnahan RM, Egge JA, et al. Inappropriate prescribing predicts adverse drug events in older adults. Ann Pharmacother 2010; 44: 957-963.
221. Schmader KE, Hanlon JT, Landsman PB, et al. Inappropriate prescribing and health outcomes in elderly veteran outpatients. Ann Pharmacother 1997; 31: 529-533.
222. Garfinkel D, Zur-Gil S, Ben-Israel J,. The war against polypharmacy: A new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J 2007; 9: 430-434.